La cadena de opciones muestra datos clave de las opciones de acciones de MBX Biosciences a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para MBX Biosciences..

MBX Biosciences (NASDAQ:MBX) Bolsa, Cadena de Opciones

MBX Biosciences

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

APLD

AZTR

CRKN

CVGW

GCTK

GLAC

HSDT

LFWD

MASS

ORKA

QBTS

QUBT

RIME

SGBX

VMAR

VRME

Descubre las acciones ganadoras y perdedoras en el premercado, con Vision Marine liderando un aumento del 45%.

Las acciones de Vision Marine (VMAR) se disparan un 45%; 20 acciones que se están moviendo en premercado

MBX Biosciences Inc

MICROBIX BIOSYSTEMS INC by Microbix Biosystems Inc.

Microbix Biosystems Inc

Economic activity expanded slightly to moderately across the Federal Reserve&#8217;s 12 districts during late November and December, yet concerns over looming changes to U.S. immigration and tariff policies cast a shadow on the future, according to the Fed <a href="https://www.benzinga.com/topic/federal-reserve">Beige Book released Wednesday. </a>
The latest Fed Beige Book report highlighted moderate growth in consumer spending, strong holiday sales and rising wages.
According to anecdotal economic insights from businesses and other contacts across the country, several Fed districts showed potential economic headwinds tied to expected policy shifts under President-elect Donald Trump.
<h3 class="wp-block-heading">How Expected Tariffs, Immigration Policies Shape Business Sentiment</h3>
Businesses are increasingly wary of the Trump administration&#8217;s plans to tighten immigration rules and impose steep tariffs. Trump has floated the idea of raising tariffs on Chinese goods to as much as 60% and applying 10% universal tariffs on imports from other nations.
The manufacturing sector appears particularly vulnerable, with contacts reporting efforts to stockpile raw materials in anticipation of higher tariffs.
Additionally, some businesses fear that restrictions on immigration could exacerbate labor shortages, especially in industries like construction and agriculture.
Business leaders across industries within the New York Fed District &#8220;expressed concern that potential import tariffs would push up prices,&#8221; the Beige Book stated.
In the Richmond Fed District, firms from various sectors expressed concerns and uncertainties about tariffs, port worker strikes and overall economic conditions heading into the new year.
<h3 class="wp-block-heading">Wage Growth Picks Up, Inflationary Pressures Remain Modest</h3>
The labor market showed signs of strength, with wage growth accelerating to a moderate pace across most districts. Yet businesses reported growing uncertainty about future staffing needs, especially in light of potential policy changes.
Prices rose modestly overall, with businesses reporting a mix of flat, moderate or even declining selling prices in certain sectors like retail and manufacturing.
Input costs, particularly for health insurance and fuel, continued to climb, and some contacts predicted that higher tariffs would contribute to broader inflation in 2025.
While inflationary pressures remain contained for now, many businesses are bracing for price hikes if the new tariffs go into effect.
The agricultural sector struggled under weak farm incomes and adverse weather conditions. The spread of avian flu further tightened egg supplies, leading to a spike in prices. Energy activity, meanwhile, was mixed, with optimism about 2025 tempered by uncertainty over global demand.
Despite these challenges, the Beige Book revealed cautious optimism for the year ahead. More contacts reported a positive outlook for 2025 than a negative one, reflecting the resilience of the U.S. economy in the face of shifting political landscape.
<h3 class="wp-block-heading">Market Reactions</h3>
Markets showed little reaction to the Fed Beige Book release. The S&amp;P 500, tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), maintained its session gains of 1.8%.
Tech stocks rallied further during early afternoon trading in New York. The Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) was 2.3% higher, eyeing its strongest session since Nov. 6, 2024, when tech stocks showed a post-election rally.
The U.S. dollar index was also little moved, with the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) down 0.1% for the day.
Crude oil added gains, with the West Texas Intermediate light crude up by over 3% to $80 a barrel by 2:20 p.m. ET. 
Read now: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43007354/big-banks-crush-q4-earnings-forecasts-financial-stocks-set-for-biggest-1-day-rally-since-trumps-election">Big Banks Crush Q4 Earnings Forecasts: Financial Stocks Set For Biggest 1-Day Rally Since Trump&#8217;s Election</a></li>
</ul>
Photo via Shutterstock.

Broad U.S. Equity ETFs

Economics

Federal Reserve

Markets

ETFs

PowerShares DB US Dollar Index Bullish Fund

Fed Beige Book Flags Moderate Growth, Yet Tariffs, Immigration Policies Spark Concerns

Pacific Gas &amp; Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>) stock has recently faced volatility amid shifting investor sentiment <a href="https://www.benzinga.com/topic/utilities">and market dynamics.</a>
Activist investor Dan Loeb&#8216;s hedge fund, Third Point, held 49.7 million shares in utility company Pacific Gas &amp; Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>) as of Sept. 30, 2024, making it the fund&#8217;s largest <a href="https://www.benzinga.com/news/large-cap/25/01/42788070/hedge-fund-giant-dan-loebs-pge-bet-beats-market">holding at the time.</a>
On Jan. 13, 2025, BMO Capital analyst James M. Thalacker initiated coverage on the company with an Outperform and<a href="https://www.benzinga.com/quote/pcg/analyst-ratings" target="_blank" rel="noreferrer noopener"> a price target of $21</a>.
The analyst writes that he views PCG shares as a core holding in the regulated utility sector, offering investors a rare combination of deep value and premium, visible growth potential.
Thalacker&#8217;s five-year forecast (2024-2028) projects EPS growth of around 9.2% and rate base growth of about 10%, aligning with the company's long-term EPS target of at least 9%.
Also, on Dec. 17, JPMorgan analysts Jeremy Tonet and Richard W. Sunderland stated that they believe PG&amp;E's wildfire mitigation investments, data center pipeline and re-rating potential <a href="https://www.benzinga.com/news/large-cap/25/01/42788070/hedge-fund-giant-dan-loebs-pge-bet-beats-market" target="_blank" rel="noreferrer noopener">could drive substantial gains</a>. 
Notably, last month, the Department of Energy disclosed plans to provide Pacific Gas &amp; Electric with a record $15 billion loan guarantee to strengthen its electrical grid and support climate resiliency initiatives.
If finalized, the loan guarantee for PG&amp;E&#8217;s Project Polaris will support hydropower, battery storage, transmission upgrades, and virtual power plants across its service area.
The Energy Department said that these infrastructure investments will enable PG&amp;E to address projected load growth, enhance electric reliability, <a target="_blank" href="https://www.energy.gov/lpo/articles/lpo-announces-conditional-commitment-pacific-gas-electric-company-expand-hydropower" rel="noreferrer noopener">and</a> lower costs for consumers throughout California.
Earlier, during its third-quarter earnings call, PCG raised its five-year capital investment plan by $1 billion, bringing the total to $63 billion for <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41800512/pg-e-corporation-reports-strong-third-quarter-results-strengthens-2024-guidance-initiates-2025-gui" rel="noreferrer noopener">the 2024-2028 period</a>.
The company also reaffirmed its equity issuance guidance <a href="https://www.benzinga.com/calendars/guidance">of $3 billion for 2025-2028</a>.
The company expects to release its fourth-quarter earnings <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">results in February 2025</a>.
Investors can gain exposure to the stock via VanEck Uranium and Nuclear ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLR#NYSE">NLR</a>) and Themes ETF Trust Themes Uranium &amp; Nuclear ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/URAN#BATS">URAN</a>).
Price Action: PCG shares are up 4.71% at $17 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42983439/la-braces-for-another-extreme-fire-weather-scenario-multiple-lawsuits-filed-against-edison-over-eaton-fire-damages" target="_blank" rel="noreferrer noopener">LA Braces For More &#8216;Extreme Fire Weather,&#8217; Multiple Lawsuits Filed Against Edison Over Eaton Fire Damages</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

Hedge Funds

Initiation

Themes ETF Trust Themes Uranium & Nuclear ETF

URAN

Dan Loeb's PG&E Play: Growth, Resilience, And $63 Billion Investments

BMI Research revised its 2025 copper price forecast to $10,000 per ton, reflecting uncertainties tied to U.S. trade policies and global economic headwinds.
What Happened: BMI expects President-elect Donald Trump's return to the White House to decelerate the<a href="https://www.benzinga.com/topic/green-energy"> green-energy transition</a> and drive a <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42436633/trump-has-a-dollar-problem-president-elect-favors-weaker-currency-but-potential-tariffs-might-end-up-strengthening-the-greenback-instead">stronger dollar via tariffs</a>.
A deceleration in the energy transition potentially looming over Trump-led policy shifts might dampen the &#8216;green sentiment&#8217; that bolstered prices in 2024," BMI's quarterly <a href="https://store.fitchsolutions.com/metals-mining/copper-report">report</a> said.
The firm also highlighted China's ongoing economic challenges, particularly in the property sector, as a drag on copper prices. Mainland China accounts for about half of global copper consumption, and its stimulus measures in late 2024 did little to offset the sector's slowdown.
Meanwhile, S&amp;P Global's analysts anticipate that any major turnaround will require significantly more policy intervention.
"A strong dollar adds downside risk to prices in 2025, with most economists downgrading growth forecasts due to expected U.S. tariff hikes," <a href="https://www.spglobal.com/commodity-insights/en/news-research/latest-news/metals/123024-commodities-2025-trump-trade-tactics-loom-over-2025-copper-demand-prices">said</a> principal analyst Ronnie Cecil. The anticipated tariffs, ranging from 10% to 100% on key imports, are expected to disrupt global trade flows and exacerbate economic pressures, particularly for export-driven economies like China.
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43011444/wall-street-rallies-as-treasury-yields-fall-banks-smash-q4-earnings-oil-hits-80-whats-driving-markets-wednesday">Wall Street Rallies As Treasury Yields Fall, Banks Smash Q4 Earnings, Oil Hits $80: What&#8217;s Driving Markets Wednesday?</a>
Why It Matters: Trade policies are dominating commodity outlooks as market fundamentals take a backseat. 
Paradigm Capital mining analyst David Davidson cautioned, "If we get a tit-for-tat trade war, then kiss global economic growth expectations goodbye." S&amp;P Global projects a modest surplus in refined copper for 2025, while deficits in copper concentrate markets persist due to insufficient mined supply.
Copper prices on the London Metal Exchange averaged $9,307 per ton in 2024 and Commodity Insights forecasts a rise to $9,825 per ton in 2025. However, the concentrate market faces significant challenges, including the prolonged shutdown of First Quantum's Cobre Panama mine, which the local government shut down in December 2023.
Without a mine that provided around 1.5% of the global supply, the estimated 52,500 metric ton deficit from 2024 could balloon to over 840,000 in 2025. Davidson noted that Cobre Panama might not resume operations until 2026.
Despite uncertainties, some industry leaders remain cautiously optimistic. Rio Tinto CEO Jakob Stausholm pointed out that previous U.S. trade policies had bolstered their operations and expressed confidence in navigating potential challenges. "We are a global business; we can cope with this," he remarked.
Other industry insiders share a similar sentiment. White &amp; Case's straw poll of 112 decision makers from the metals &amp; mining sector noted copper as the <a href="https://www.whitecase.com/sites/default/files/2025-01/mining-metals-2025-market-sentiment-survey-results.pdf">number one pick</a> to outperform in 2025. Still, insiders align with market research firms, ranking geopolitical risks at the top of the industry's short-term hurdles.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/42894609/chile-rejects-dominga-project-once-again-taps-debt-market-to-help-its-copper-growth">Chile Rejects Dominga Project Once Again, Taps Debt Market To Help Its Copper Growth</a></li>
</ul>
Image: Shutterstock

Price Target

Commodities

Analyst Ratings

Research Firms And Industry Insiders Clash On Copper, Agree On Trump's Risk

The International Energy Agency has revised its <a target="_blank" href="https://www.benzinga.com/topic/oil" rel="noreferrer noopener">global oil demand</a> outlook slightly for 2025, projecting growth of 1.05 million barrels per day, down from <a target="_blank" href="https://www.iea.org/reports/oil-market-report-december-2024" rel="noreferrer noopener">the previously estimated</a> 1.1 million barrels daily.
The new forecast anticipates global demand will average 104 million barrels daily, reflecting a combination of improving economic conditions and <a target="_blank" href="https://www.iea.org/reports/oil-market-report-january-2025" rel="noreferrer noopener">lower fuel prices</a>.
In the fourth quarter of 2024, oil demand rebounded strongly, increasing by 1.5 million barrels daily—the highest growth since late 2023.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42980720/microsoft-taps-meta-veteran-to-lead-new-coreai-division-plans-shift-from-openai-dependence" rel="noreferrer noopener">Microsoft Launches CoreAI Division: Ex-Meta Exec To Supercharge Copilot And AI Innovations</a>
The IEA attributed this surge to reduced fuel prices, colder weather in northern regions, and heightened petrochemical activity in the U.S. However, while 2025 demand growth will likely surpass 2024, it will fall short of the over 2 million barrels per day increase seen in 2023.
OPEC projects a higher demand growth of <a target="_blank" href="https://momr.opec.org/pdf-download/" rel="noreferrer noopener">1.45 million barrels daily</a>.
<a target="_blank" href="https://www.benzinga.com/markets/commodities/24/11/41899890/opec-cuts-2024-oil-demand-forecast-for-fourth-straight-month-amid-chinas-economic-slowdown" rel="noreferrer noopener">Disappointing data from</a> major Asian markets, including China, India, and African countries, prompted OPEC to revise its oil demand growth forecasts for 2024 several times.
Still, OPEC&#8217;s estimates looked more optimistic than those of Wall Street banks and Saudi Aramco.
China saw a significant uptick in oil demand in November, driven by rising gasoil consumption and falling diesel prices, which hit their lowest in nearly three years.
The IEA highlighted that signs of stabilization in China&#8217;s property market could support further recovery in oil demand. Projections suggest China will add 220,000 barrels per day to its oil consumption in 2025, compared to a 180,000-barrel daily increase in 2024, the Wall Street Journal <a target="_blank" href="https://www.wsj.com/business/energy-oil/iea-trims-oil-demand-outlook-but-still-expects-stronger-growth-this-year-a972c71b?mod=business_lead_pos4" rel="noreferrer noopener">reports</a>.
Recent U.S. sanctions targeting Russia&#8217;s energy sector and shipping networks and measures aimed at Iran&#8217;s shadow fleet could disrupt global oil supplies. These actions may compel major buyers like China and India to seek alternative sources.
Meanwhile, Brent crude prices hover around $80 per barrel, and U.S. West Texas Intermediate trades near $77 per barrel, reflecting market concerns over tightened supply, the WSJ reports.
Despite geopolitical pressures, global oil supply rose modestly in December 2024, supported by increased production in Nigeria and Libya. For 2025, the IEA forecasts supply growth of 1.8 million barrels daily, led by non-OPEC+ countries such as the U.S., Brazil, and Canada. However, the agency cautioned that sanctions or weather-related disruptions could rapidly draw down existing oil stocks.
Notable oil stocks include Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), Shell Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>), TotalEnergies SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>), Petroleo Brasileiro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBR#NYSE">PBR</a>) and BP Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>).
Investors can gain exposure to the crude oil market through the United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) and ProShares Ultra Bloomberg Crude Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UCO#NYSE">UCO</a>).
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/42974632/us-listed-chinese-stocks-rally-on-strong-trade-data-central-bank-support-goldman-forecasts-20-growth" target="_blank" rel="noreferrer noopener">US Listed Chinese Stocks Rally on Strong Trade Data, Central Bank Support, Goldman Forecasts 20% Growth</a></li>
</ul>
Photo by William Potter on Shutterstock

News

Guidance

Trading Ideas

SHEL

OPEC's Optimism Clashes With IEA's Conservative 2025 Oil Growth Projections

Deep-pocketed investors have adopted a bullish approach towards Caesars Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CZR usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Caesars Entertainment. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $335,085, and 4 are calls, amounting to $130,913.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $42.0 for Caesars Entertainment over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Caesars Entertainment stands at 3474.33, with a total volume reaching 6,440.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Caesars Entertainment, situated within the strike price corridor from $30.0 to $42.0, throughout the last 30 days.
<h3>Caesars Entertainment Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736970375_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CZR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/28/25</td>
<td>$1.41</td>
<td>$1.25</td>
<td>$1.33</td>
<td>$32.00</td>
<td>$198.9K</td>
<td>2</td>
<td>1.5K</td>
</tr>
<tr>
<td>CZR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$9.25</td>
<td>$9.15</td>
<td>$9.25</td>
<td>$42.00</td>
<td>$63.8K</td>
<td>237</td>
<td>69</td>
</tr>
<tr>
<td>CZR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$8.4</td>
<td>$8.25</td>
<td>$8.4</td>
<td>$41.00</td>
<td>$43.6K</td>
<td>49</td>
<td>52</td>
</tr>
<tr>
<td>CZR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.29</td>
<td>$1.17</td>
<td>$1.26</td>
<td>$32.50</td>
<td>$41.9K</td>
<td>1.8K</td>
<td>522</td>
</tr>
<tr>
<td>CZR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$0.18</td>
<td>$0.17</td>
<td>$0.17</td>
<td>$35.00</td>
<td>$31.4K</td>
<td>17.1K</td>
<td>3.3K</td>
</tr>
</tbody>
</table>

<h3>About Caesars Entertainment</h3>
Caesars Entertainment includes about 50 domestic gaming properties across Las Vegas (49% of 2023 EBITDAR before corporate expenses) and regional (48%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced marginal EBITDA in 2023. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
In light of the recent options history for Caesars Entertainment, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Caesars Entertainment's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,250,241, with CZR's price up by 1.66%, positioned at $33.74.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 41 days.</li>
</ul>
<h3>What Analysts Are Saying About Caesars Entertainment</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $49.333333333333336.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Caesars Entertainment, targeting a price of $57. 
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Caesars Entertainment with a target price of $43. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Caesars Entertainment with a target price of $48. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Caesars Entertainment options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

This Is What Whales Are Betting On Caesars Entertainment

Edison International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) shares are trading higher on Wednesday. Brokerage firm <a href="https://www.benzinga.com/analyst-ratings/upgrades/25/01/43010675/edison-international-shares-are-moving-higher-wednesday-whats-driving-the-action">Ladenburg Thalman upgraded the stock from Sell to Neutral</a>. They believe the recent sell-off is overdone.
The chart of Edison illustrates that even when there is significant news regarding a company, it is still important for traders and investors to understand technical analysis dynamics. This is why it is our Stock of the Day.
The sell-off was driven by concerns about the potential impact caused by the Los Angeles fires. Edison is an electric power generator and distributor that operates in Southern California. The company will lose revenue because it is no longer supplying energy to the destroyed areas.
There are also concerns over possible legal issues. A lawsuit has been filed alleging that faulty equipment owned by Edison started the fire.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="545" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15143839/1-6-1024x545.png" alt="" class="wp-image-735468" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15143839/1-6-1024x545.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15143839/1-6-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15143839/1-6-768x409.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15143839/1-6.png 1528w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/news/earnings/25/01/43007354/big-banks-crush-q4-earnings-forecasts-financial-stocks-set-for-biggest-1-day-rally-since-trumps-election">Big Banks Crush Q4 Earnings Forecasts: Financial Stocks Set For Biggest 1-Day Rally Since Trump&#8217;s Election</a>
Despite this news, as you can see on the chart technical analysis dynamics still come into play.
In financial markets, certain price levels are more important than others. These are called support and resistance levels.
&#8220;Markets have memories&#8221; is an old Wall Street expression. It means important price levels can retain their importance for a long time. It could be weeks, months or even years.
The $55 level has been support for Edison since October 2020. Each time the stock dropped to this price, the buyers flooded the market and put a floor under the stock.
This isn't a coincidence. There tends to be support at prices that were support previously.
Some investors and traders regret selling at a support level if the price rallies after. A number of these remorseful sellers decide that if they can, they will buy their shares back at the same price they were sold.
As a result, if and when the stock reverses and drops back to the support level they place buy orders. If there is a significant number of these orders, it will create support at the same price where there had been support before.
Markets do in fact, have memories. The chart of Edison International shows it. The $55 has been a support level for more than four years.
Read Next: • <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43001512/inflation-rises-to-29-in-december-core-slows-yet-rising-energy-costs-put-feds-target-at-risk">Inflation Rises To 2.9% In December: Core Slows, Yet Rising Energy Costs Put Fed&#8217;s Target At Risk</a>
Photo: Shutterstock

Technicals

Stock Of The Day: Time To Buy Edison International?

Financial giants have made a conspicuous bullish move on Fair Isaac. Our analysis of options history for Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) revealed 15 unusual trades.
Delving into the details, we found 53% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $603,426, and 9 were calls, valued at $652,780.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $1400.0 and $3200.0 for Fair Isaac, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Fair Isaac stands at 17.22, with a total volume reaching 85.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Fair Isaac, situated within the strike price corridor from $1400.0 to $3200.0, throughout the last 30 days.
<h3>Fair Isaac Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736970370_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$265.0</td>
<td>$255.0</td>
<td>$261.0</td>
<td>$1800.00</td>
<td>$182.7K</td>
<td align="right">15</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$39.8</td>
<td>$33.9</td>
<td>$36.9</td>
<td>$1820.00</td>
<td>$147.6K</td>
<td align="right">53</td>
<td align="right">40</td>
</tr>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$246.0</td>
<td>$227.5</td>
<td>$234.0</td>
<td>$1830.00</td>
<td>$140.4K</td>
<td align="right">6</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$32.0</td>
<td>$30.7</td>
<td>$31.95</td>
<td>$1800.00</td>
<td>$127.8K</td>
<td align="right">40</td>
<td align="right">40</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1196.6</td>
<td>$1186.6</td>
<td>$1196.6</td>
<td>$3200.00</td>
<td>$119.6K</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>

<h3>About Fair Isaac</h3>
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
<h3>Fair Isaac's Current Market Status</h3>
<ul>
<li>Trading volume stands at 86,729, with FICO's price up by 2.08%, positioned at $1990.0.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 12 days.</li>
</ul>
<h3>What Analysts Are Saying About Fair Isaac</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $2278.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Fair Isaac, targeting a price of $2409. 
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Fair Isaac with a target price of $2275. 
&#x2A; An analyst from JP Morgan has revised its rating downward to Neutral, adjusting the price target to $2150. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Fair Isaac options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

FICO

Check Out What Whales Are Doing With FICO

Investors with a lot of money to spend have taken a bearish stance on Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AFRM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 14 uncommon options trades for Affirm Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 35% bullish and 42%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $490,542, and 11 are calls, for a total amount of $2,441,236.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $7.5 to $67.5 for Affirm Holdings over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Affirm Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Affirm Holdings's substantial trades, within a strike price spectrum from $7.5 to $67.5 over the preceding 30 days.
<h3>Affirm Holdings Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736970365_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$18.5</td>
<td>$18.4</td>
<td>$18.4</td>
<td>$60.00</td>
<td>$1.8M</td>
<td>774</td>
<td>1.0K</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$14.65</td>
<td>$14.6</td>
<td>$14.65</td>
<td>$65.00</td>
<td>$323.7K</td>
<td>499</td>
<td>221</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$0.8</td>
<td>$0.75</td>
<td>$0.93</td>
<td>$60.00</td>
<td>$240.0K</td>
<td>7.2K</td>
<td>4.6K</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$17.25</td>
<td>$16.0</td>
<td>$16.0</td>
<td>$60.00</td>
<td>$128.0K</td>
<td>409</td>
<td>0</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$3.8</td>
<td>$3.65</td>
<td>$3.74</td>
<td>$67.50</td>
<td>$90.0K</td>
<td>453</td>
<td>429</td>
</tr>
</tbody>
</table>

<h3>About Affirm Holdings</h3>
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.
In light of the recent options history for Affirm Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Affirm Holdings</h3>
<ul>
<li>Trading volume stands at 5,826,887, with AFRM's price up by 4.3%, positioned at $57.73.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 22 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Affirm Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

AFRM

Affirm Holdings's Options Frenzy: What You Need to Know

Legal

PARA

PARAA

Paramount Deal Should Get CFIUS Scrutiny, House Member Says

Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) scored big with its first NFL Playoffs exclusive stream, airing the recent Pittsburgh Steelers and Baltimore Ravens matchups during the<a href="https://www.benzinga.com/general/sports/25/01/42829221/how-to-watch-nfl-playoffs-super-bowl-lix-betting-odds-will-history-be-made-by-chiefs-or-lions"> first week of the postseason.</a>
What Happened: Amazon set a new <a href="https://www.benzinga.com/topic/streaming">Prime Video</a> NFL record with an average of 22.07 million viewers during the Steelers and Ravens matchup, which the Ravens won 28-14 and advanced.
The record tops the 17.92 million Amazon's Prime Video had for a regular season game between the Detroit Lions and Green Bay Packers earlier this season. That match was the most streamed game during the season, before Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) set the 2024 NFL streaming record<a href="https://www.benzinga.com/general/sports/24/12/42711504/lebron-james-vs-nfl-nba-star-says-christmas-is-our-day-2024-ratings-paint-a-different-picture"> on Christmas Day.</a>
Amazon has the rights to "Thursday Night Football" games and has regularly shared that the NFL games have provided a boost to Prime subscribers and also helped with advertising revenue.
The NFL Playoffs game sets a new bar for Amazon in its sports streams and the NFL partnership, as <a href="https://www.hollywoodreporter.com/tv/tv-news/nfl-wild-card-2025-tv-ratings-prime-video-fox-1236108797/">reported </a>by The Hollywood Reporter. While the viewership was high and the game hit a peak of 24.66 million viewers during the game, the viewership trails several other media companies in their NFL coverage.
This is the second straight year the NFL has featured a NFL Playoffs game exclusive to a streaming platform. Last year, Comcast Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) streamed a NFL Playoffs game between the Kansas City Chiefs and Miami Dolphins on Peacock.
That game had average viewership of 22.86 million, which ranks ahead of Amazon's game this season.
Also ranking ahead of Amazon are both Christmas Day games that streamed on Netflix with average viewership of 24.1 million and 24.3 million.
Read Also: <a href="https://www.benzinga.com/general/psychology/25/01/42964097/nfl-star-helps-self-help-book-hit-1-on-amazon-my-teammates-call-it-the-recipe">NFL Star Helps Self-Help Book Hit #1 On Amazon: &#8216;My Teammates Call It The Recipe&#8217;</a>
Why It's Important: Amazon's NFL Playoffs match was also the least watched of the first weekend of games.
Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) had average viewership of 35.89 million for the Philadelphia Eagles and Green Bay Packers game on Fox. Comcast had a viewership of 29 million for the Washington Commanders and Tampa Bay Buccaneers game. These games had viewership down 11% and 19% year-over-year respectively from last year.
CBS, which is a unit of Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>), had two games over the first weekend with average viewership of 26.6 million for the Los Angeles Chargers and Houston Texans game and average viewership of 31.2 million for the Buffalo Bills and Denver Broncos game. These games saw an increase in viewership compared to last year.
Monday's contents between the Los Angeles Rams and Minnesota Vikings, which aired on Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) units ABC, ESPN and ESPN2, had average viewership of 25.34 million, down 13% from last year's opening weekend Monday night game.
Four games will be played in the second weekend of the NFL Playoffs with Disney, Fox, Comcast and Paramount each having one contest.
Amazon's Playoffs game could serve as a continued test of how streaming viewership matches up against broadcast channels. This year's playoffs showed that so far more viewers watched on broadcast than on streaming.
The fact that Amazon's Playoffs game also fell shy of Netflix's Christmas Day viewership for NFL games could also prove costly if the two streaming platforms go head-to-head on sports rights in the future.
Amazon had a successful season of NFL viewership in 2024, with an average of 13.2 million viewers for its "Thursday Night Football" games, up 11% year-over-year, as <a href="https://frontofficesports.com/amazons-nfl-ratings-rose-13-in-2024-a-playoff-game-is-next/">reported </a>by FrontOfficeSports.
The company also streamed a second annual Black Friday game on Prime Video. When that game is counted into the games, Amazon's 2024 NFL viewership averaged 13.5 million viewers and was up 13% year-over-year.
Amazon has come a long ways from the 9.58 million average viewers it had for "Thursday Night Football" games in 2022.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/sports/25/01/42884959/detroit-lions-take-a-bite-out-of-sportsbooks-analyst-advises-patience-after-flutter-cuts-guidance">Detroit Lions Take Bite Out Of Sportsbooks: Analyst Advises Patience After Flutter Cuts Guidance</a></li>
</ul>
Photo: Shutterstock

Entertainment

Sports

AMZN

CMCSA

FOXA

NFLX

Amazon Scores Record With Steelers, Ravens NFL Playoffs Stream: How Game Stacks Up With Other Media, Streamers

Uber Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) shares are trading higher by 3.15% to $66.88 during Wednesday&#8217;s session amid overall market strength. The <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43011444/wall-street-rallies-as-treasury-yields-fall-banks-smash-q4-earnings-oil-hits-80-whats-driving-markets-wednesday">December inflation report</a>, showing a slowdown in core price pressures, has reduced concerns about the Federal Reserve&#8217;s aggressive stance on interest rates.
What To Know: As the probability of <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43003047/stocks-rise-on-core-inflation-slowdown-banks-rally-after-strong-q4-earnings-treasury-yields-plummet">rate cuts</a> in 2025 increases, Uber stands to benefit from a more favorable financing environment, potentially lowering its borrowing costs and improving profitability.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/01/43007218/why-intuitive-surgical-shares-are-surging-wednesday">Why Intuitive Surgical Shares Are Surging Wednesday</a>
Additionally, the prospect of a rate cut enhances consumer confidence, which may drive more demand for Uber's services. A more stable economic environment may encourage discretionary spending, including ridesharing and delivery services.
Lower borrowing costs could also enable Uber to accelerate its expansion plans, invest in new technologies or explore strategic acquisitions.
Uber&#8217;s stock price is likely buoyed Wednesday by the belief that economic conditions will support the company's long-term growth.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43011444/wall-street-rallies-as-treasury-yields-fall-banks-smash-q4-earnings-oil-hits-80-whats-driving-markets-wednesday">Wall Street Rallies As Treasury Yields Fall, Banks Smash Q4 Earnings, Oil Hits $80: What&#8217;s Driving Markets Wednesday?</a>
<h2 class="wp-block-heading">How To Buy UBER Stock</h2>
By now you're likely curious about how to participate in the market for Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
In the the case of Uber Technologies, which is trading at $66.89 as of publishing time, $100 would buy you 1.49 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, UBER has a 52-week high of $87.00 and a 52-week low of $54.84.

UBER

What's Going On With Uber Stock?

Macro Economic Events

Market Summary

General

Benzinga Market Summary: S&P Rises Following Dec. CPI And Strong Bank Earnings, Israel And Hamas Reach Hostage And Ceasefire Agreement

Marvell Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) shares are trading higher by 0.99% to $116.35 during Wednesday&#8217;s session amid the broader market&#8217;s positive reaction to <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43003047/stocks-rise-on-core-inflation-slowdown-banks-rally-after-strong-q4-earnings-treasury-yields-plummet">December inflation data</a>.
The report showing slowing underlying price pressures is a positive signal for the broader economy, fueling investor optimism that the Federal Reserve may soon implement further rate cuts. 
What Else: For Marvell, <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43001512/inflation-rises-to-29-in-december-core-slows-yet-rising-energy-costs-put-feds-target-at-risk">lower interest rates</a> reduce the cost of capital and could help spur investment in data centers, cloud computing, and 5G technologies—key areas in which Marvell plays a crucial role. 
As a semiconductor supplier that powers these industries, Marvell stands to gain from increased demand as businesses expand their infrastructure in response to favorable economic conditions.
Additionally, with semiconductor stocks often benefiting from a lower cost of financing, Marvell could see further upside as the probability of rate cuts in 2025 rises.
Read Also: <a href="https://www.benzinga.com/general/market-summary/25/01/42996490/nordea-parisi-gray-graypoint-load-up-on-marvell-technology-shares-iaim-dilutes-98-in-q4-heres-what-mrvls-technical-analysis-says">Nordea, Parisi Gray, Graypoint Load Up On Marvell Technology Shares, IAIM Dilutes 98% In Q4: Here&#8217;s What MRVL&#8217;s Technical Analysis Says</a>
Investors can gain exposure to&nbsp;MRVL by&nbsp;investing&nbsp;in the VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>).
<h2 class="wp-block-heading">How To Buy MRVL Stock</h2>
By now you're likely curious about how to participate in the market for Marvell Technology &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
In the the case of Marvell Technology, which is trading at $116.72 as of publishing time, $100 would buy you 0.86 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MRVL has a 52-week high of $126.12 and a 52-week low of $53.19.

MRVL

What's Going On With Marvell Technology (MRVL) Stock?

Defense stocks are moving slightly lower Wednesday after Israel and Hamas verbally agreed on a <a href="https://www.benzinga.com/25/01/43011383/israel-gaza-ceasefire-hostage-exchange">ceasefire in Gaza</a>.
What Happened: Hamas accepted a draft agreement on Wednesday for a ceasefire in Gaza that includes the release of several hostages, according to <a href="https://www.benzinga.com/25/01/43011383/israel-gaza-ceasefire-hostage-exchange">multiple reports</a>. 
The agreement follows months of negotiations and paves the way for a potential end to the ongoing war in the Middle East that began about 15 months ago. The verbal agreement also comes just days before President-elect Donald Trump&#8217;s inauguration. 
&#8220;We have a deal for the hostages in the Middle East. They will be released shortly. Thank you!&#8221; Trump&nbsp;said in a post on Truth Social.
The deal reportedly includes a six-week ceasefire and the release of 33 Israeli hostages in exchange for the release of Palestinian prisoners. Israel still needs to ratify the deal, but a vote is expected by Thursday. 
Related Link: <a href="https://www.benzinga.com/25/01/43011383/israel-gaza-ceasefire-hostage-exchange">Israel, Hamas Agree To Cease-Fire Deal With Hostage Exchange: What You Need To Know</a>
Defense stocks including Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), Northrop Grumman Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) and RTX Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) moved lower as the ceasefire reports surfaced despite a strong session from broader indices. The Global X Funds Global X Defense Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>) and the SPDR S&amp;P Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XAR#NYSE">XAR</a>) also pulled back from highs on the news. 
At the time of writing, Lockheed Martin shares were down about 0.7%, while Northrop Grumman and RTX shares were down about 0.8%. It&#8217;s worth noting that the SPDR S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 1.77% at last check.
Defense stocks have benefitted from the ongoing war in the Middle East with the Global X Funds Defense ETF having gained more than 35% over the past year, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Defense stocks tend to rally in periods of elevated conflict given their heavy reliance on government contracts. 
Energy stocks including BP P.L.C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>), Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) and ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) also pulled back slightly on the ceasefire news, but bounced back pretty quickly. 
The United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) hit new 52-week highs on Wednesday on continued momentum from last week after the U.S. announced its most extensive sanctions on Russian oil exports to date.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42948649/goldman-sachs-warns-of-90-oil-risk-trump-may-not-ease-sanctions-once-he-takes-office">Oil Could Hit $90, Goldman Sachs Says: &#8216;Trump May Not Ease Sanctions&#8217; On Russia</a></li>
</ul>
Photo: courtesy of Lockheed Martin.

Global

Movers

SHLD

Defense Stocks Fall On Gaza Ceasefire While Broader Market Rallies: What's Going On?

Denali Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) CEO Ryan Watts presented at the J.P. Morgan Healthcare Conference.&nbsp;
The presentation primarily focused on&nbsp;the company&#8217;s blood-brain-barrier (BBB) crossing platform technology and the pipeline, including tividenofusp alfa (tivi, DNL310) in Hunter syndrome and DNL126 in Sanfilippo syndrome Type A,&nbsp;as well as ATV:Abeta approach in Alzheimer&#8217;s disease.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/42856965/denali-therapeutics-amyotrophic-lateral-sclerosis-misses-pivotal-trial-but-analyst-says-it-was-expected" rel="noreferrer noopener">Denali Therapeutics&#8217; Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected</a>
JP Morgan notes that the management believes each TV franchise has the potential to generate over $3 billion in value.
The analyst views Denali Therapeutics as being in the early stages of unlocking the full potential of its BBB TV platform across various applications, maintaining the stock&#8217;s Overweight rating.
Ahead of the conference, DNL310 received Breakthrough Therapy Designation in Hunter Syndrome and is on track to file a BLA for accelerated approval in early 2025. Based on this timeline, JP Morgan expects a potential late-2025/early 2026 launch.
<ul>
<li>The company is gearing up for commercialization and product launch, focusing initially on the U.S. market. Management estimates there are approximately 400-500 patients in the U.S.</li>
<li>Meanwhile, the Phase 2/3 COMPASS trial has completed enrollment for neuronopathic participants in cohort A. Both study cohorts are expected to have simultaneous results, but no timeline for the readout has been provided. Globally, management estimates around 2,000 patients.</li>
</ul>
On DNL126, the management did not share detailed data but emphasized promising results from the Phase 1/2 trial in Sanfilippo syndrome Type A.
These include DNL126&#8217;s ability to normalize CSF HS levels. Building on these findings and insights from DNL310, the company is working to speed up DNL126&#8217;s development timeline.
To support this, they expanded the Phase I/II trial from two to five cohorts, aiming for a faster approval pathway. Management estimates a global patient population of over 1,500.
JP Morgan also notes that Denali Therapeutics has a manufacturing facility. While it won&#8217;t be used for the commercial launch of Tivi in Hunter syndrome, it is expected to support the company&#8217;s other programs.
As of September 30, 2024, cash, cash equivalents, and marketable securities were approximately $1.28 billion. Denali anticipates its cash runway <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42942702/denali-therapeutics-announces-key-anticipated-2025-milestones-and-priorities-to-further-advance-it" rel="noreferrer noopener">will extend into 2028</a>.
Price Action: DNLI stock is up 14.60% at $21.48 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/43010888/ftc-says-unitedhealth-cvs-cigna-make-billions-via-pbms-on-specialty-drugs" target="_blank" rel="noreferrer noopener">FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs</a></li>
</ul>

Analyst Color

Biotech

Health Care

DNLI

Why Is Denali Therapeutics Stock Trading Higher On Wednesday?

Contracts

LUNR

Intuitive Machines Mentioned As Part of $4.82B Contract From NASA For 'Near Space Network Services - Contract Award'

Scholar Rock Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>) President &amp; CEO Jay Backstrom presented at the J.P. Morgan <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42885696/scholar-rock-highlights-2025-strategic-priorities" rel="noreferrer noopener">Healthcare Conference</a>.
The discussions mainly focused on apitegromab for spinal muscular atrophy (SMA), including its label if approved. They also covered commercial aspects such as the prevalence of SMA, the potential market, and factors influencing its adoption.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41208885/scholar-rocks-muscle-wasting-drug-excels-in-pivotal-trial-plans-fda-submission-next-year" rel="noreferrer noopener">Scholar Rock&#8217;s Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year</a>
<ul>
<li>Regarding apitegromab in SMA, the company plans to submit U.S. and European marketing applications in the first quarter of 2025, aiming for a potential U.S. launch in the fourth quarter of 2025, followed by a European launch.</li>
<li>Detailed results from the phase 3 SAPPHIRE trial, which involves patients with non-ambulatory type 2/3 SMA treated with Spinraza (nusinersen) or Evrysdi (risdiplam), are expected to be presented at medical meetings in 2025.</li>
<li>By mid-2025, the company aims to start the phase 2 OPAL trial, focusing on patients under 2 years old to understand how the drug behaves and guide dosing.</li>
<li>Regarding the addressable market, the company estimates the current SMA market at around $4.5 billion across three SMN-targeted therapies, mainly in the 2-21-year-old age group. They now expect apitegromab to reach over $2 billion in global revenue, an increase from previous estimates of $1 billion, driven by strong data and a favorable competitive landscape.</li>
</ul>
The analyst also discussed the upcoming results from the Phase 2 EMBRAZE trial, which is evaluating apitegromab combined with tirzepatide or semaglutide in adults who are overweight or obese. The data is expected in the second quarter of 2025.
JP Morgan remains positive on Scholar Rock (<a href="https://www.benzinga.com/quote/SRRK/analyst-ratings" target="_blank" rel="noreferrer noopener">Overweight rating</a>), as the recent SAPPHIRE trial results have unlocked strong growth potential for apitegromab in spinal muscular atrophy. The company could enter the commercial stage by 2025, and the analyst expects a strong product launch.
The analyst also sees potential for further value in the stock if the cardiometabolic data shows positive results, with initial data expected in the second quarter of 2025.
Price Action: SRRK stock is up 4.89% at $43.56 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43010389/why-nxp-semiconductors-stock-is-seeing-blue-skies-on-wednesday" target="_blank" rel="noreferrer noopener">NXP Semiconductors Secures $1 Billion European Investment Bank Loan For R&amp;D Expansion: Details</a></li>
</ul>
Photo via Shutterstock.

Reiteration

SRRK

Scholar Rock Sets Sights on $2 Billion Apitegromab Revenue Amid Spinal Muscular Atrophy Market Growth

Just before the JP Morgan healthcare conference, Eli Lilly and Co&nbsp;(NYSE:&nbsp;LLY) announced that it expects 2024 full-year worldwide revenue to be approximately&nbsp;$45.0 billion, representing a 32% growth compared to the previous year versus the&nbsp;<a target="_blank" href="https://www.benzinga.com/25/01/42976923/eli-lilly-expects-around-55-billion-sales-from-weight-lossdiabetes-drugs-with-overall-topline-growth-of-32-issues-2025-forecast" rel="noreferrer noopener">consensus of $45.50 billion</a>.
The company's expected 2024 revenue is&nbsp;$400 million, or about 3%, below the guidance range issued during the&nbsp;third-quarter earnings. The guidance includes approximately&nbsp;$3.5 billion&nbsp;for Mounjaro and $1.9 billion&nbsp;for Zepbound.
During the conference, David Ricks outlined two reasons for the guidance update:
<ul>
<li>The diabetes GLP market, in December, outperforms the rest of the quarter and in year this did not happen&#8230;The CEO said this could be just a guess. The company said it did not predict it. "This year that didn't happen in GLP-1," said Ricks, who speculated that changes in Medicare Part D and insurance edits have prevented patients from doubling up their prescriptions at the end of the year to avoid deductible costs early in the following year."</li>
<li>Stocking levels were a big discussion during Q3 results. The company dropped about 8 selling days in that quarter alone. The company expected a buildback at the end of the year because every year, a couple of days of buildback happen, and it did not happen this year.</li>
</ul>
Regarding the guidance approach, the CEO noted, "The scale of this business and the way it's been growing, the consumer part of it, along with the stocking dynamics, it's just been a learning [experience] for us," Ricks said. "Our forecasters really nailed the rest of the portfolio. We don't have a problem with forecasting. It's just, this market is quite different."
Goldman analyst Chris Shibutani writes, "We expect this preliminary 4Q results to heighten concerns relating to underlying demand dynamics, which initially emerged at a broader level amongst investors during the 3Q results and guidance update."
Price Action: LLY stock is up 0.59% at $749.28 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/01/43004444/intel-plans-to-spin-off-5-billion-venture-capital-segment-will-remain-anchor-investor" target="_blank" rel="noreferrer noopener">Intel Plans To Spin Off $5 Billion Venture Capital Segment, Will Remain Anchor Investor</a></li>
</ul>
Photo via Eli Lilly and Company

Eli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall

BIO-Key International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) shares are moving higher on Wednesday after the company announced that the National Bank of Egypt is <a href="https://www.benzinga.com//node/43000097">deploying its PortalGuard platform</a>. 
The Details: The deployment of BIO-Key&#8217;s PortalGuard will secure access to the bank&#8217;s applications by leveraging PortalGuard&#8217;s advanced Multi-Factor Authentication and Single Sign-On capabilities.
The implementation of PortalGuard is being done in collaboration with Raya Information Technology. Raya will manage the deployment and coordinate technology vendor resources to implement the process smoothly.
&#8220;By securing all access points with multi-factor authentication and eliminating the need for multiple credentials, NBE can now provide employees with Single Sign-On access to all their applications,&#8221; said Alex Rocha, Managing Director BIO-key EMEA. 
The company said its next goal is to deliver PortalGuard's capabilities to millions of consumers and businesses.
Nicholas Prinz, Regional Director, Middle East and Africa at BIO-key, said &#8220;This project highlights the growing need for advanced identity solutions in the Middle East and Africa. We are proud to collaborate with Raya Information Technology to deliver cutting-edge solutions that meet the demands of such a prestigious institution as the National Bank of Egypt.&#8221;&nbsp;
Related Link: <a href="https://www.benzinga.com/insights/options/25/01/43012229/decoding-visas-options-activity-whats-the-big-picture">Decoding Visa&#8217;s Options Activity: What&#8217;s the Big Picture?</a>
BKYI Price Action: At the time of writing, BIO-Key stock is trading 56.2% higher at $2.14, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Via Shutterstock

BKYI

What's Going On With BIO-Key International Stock Wednesday?

Morpheus, a platform focused on launching Smart Agents, has introduced a $10 million rewards program in its native MOR token specifically designed for its community of builders.
This initiative, which went live on the Base network, follows a similar rewards program for AI Compute Providers, a step forward in Morpheus&#8217; ongoing strategy to develop an economic ecosystem for decentralized AI.
The move is aimed at attracting developers to build and contribute to the platform, particularly in the rapidly growing field of AI agents.
The builder rewards program incentivizes developers to create various components for the Morpheus platform, including Smart Agents themselves, user interfaces, decentralized applications (dApps), and other tools. 
This structure is intended to encourage a vibrant and multifaceted ecosystem that supports all aspects of agent creation and deployment. 
Morpheus is positioning itself as an all-in-one platform, emphasizing its ability to offer developers access to funding, computation, and streamlined agent deployment, aiming to provide an advantage over other projects that only focus on a single area.
Central to Morpheus&#8217; system is its four-pronged approach, which recognizes contributions from code, capital, compute and builders.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43008666/sec-under-trump-administration-to-revise-crypto-policies-report">SEC Under Trump Administration To Revise Crypto Policies: Report</a>
The rewards system seeks to compensate all participants equitably in MOR tokens, promoting a self-sustaining ecosystem. 
Moreover, holders of the MOR token are entitled to a share of the network's compute power, allowing agents continuous access to resources. 
The tokenomics of the network is designed to support the development of decentralized AI applications, with the long term goal of fostering a broad community around the project.
According to Morpheus open-source contributor David Johnston, this launch positions Morpheus at the forefront of the current AI agent expansion, welcoming agents from diverse chains and frameworks. 
This is intended to be a move towards a more universal platform for AI agent creation. 
The underlying incentive is that this allows compute and builder tokenomics to work together efficiently to reward developers fairly and in a permissionless fashion.
Morpheus operates as a decentralized AI network that optimizes the use of computational power. 
It offers users a ChatGPT-like interface that allows interaction via decentralized data routing. 
The network also provides access to personal AIs, facilitates crypto payments for AI services, features an AI marketplace, and allows for generating images via multiple Large Language Models (LLMs). 
The platform is supported by an open-source community, as well as partnerships with projects like Lumerin. 
The core of the offering is that it provides a wide ranging set of tools to work within this decentralized AI ecosystem.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43008361/dubai-announces-crypto-tower-to-host-blockchain-businesses">Dubai Announces &#8216;Crypto Tower&#8217; To Host Blockchain Businesses</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Morpheus Incentivizes AI Agent Development With $10M Builder Rewards

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on MBX Biosciences, Inc. (MBX – Research Report) and Ze...

Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and Zenas BioPharma, Inc. (ZBIO)

MBX Biosciences, Inc. (MBX) has received a new Buy rating, initiated by Jefferies analyst, Michael Yee. Michael Yee has given his Buy rating due to...

Buy Rating Affirmed for MBX Biosciences on Strong Clinical Progress and Robust Financial Position

Seamus Fernandez, an analyst from Guggenheim, has initiated a new Buy rating on MBX Biosciences, Inc. (MBX). Seamus Fernandez has given his Buy rat...

Buy Rating Affirmed on MBX Biosciences, Inc. Based on Promising Therapeutic Pipeline and Market Potential

MBX Bio drops despite bullish views on Street

MBX Biosciences, Inc. GAAP EPS of -$2.78 misses by $0.18

MBX Biosciences, Inc. ( ($MBX) ) has released its Q3 earnings. Here is a breakdown of the information MBX Biosciences, Inc. presented to its invest...

MBX Biosciences Reports Q3 2024 Financial Progress

MBX Biosciences: Decent Potential For Lead Indication, But Need More Data

MBX Biosciences (MBX) completed the last subject's last visit in its Phase 1 single and multiple ascending dose trial of MBX 1416, the company's lo...

MBX Biosciences completes last visit in Phase 1 MBX 1416 trial in hypoglycemia

MBX Biosciences (MBX) announced the publication of a peer-reviewed article highlighting results from the Phase 1 study of MBX 2109, the Company's p...

MBX Biosciences announces publication of MBX 2109 Phase 1 study results

MBX Biosciences (MBX) announced positive results from its Phase 1 single ascending dose, SAD, and multiple ascending dose, MAD, clinical trial of M...

Comments

MBX Biosciences

MBX Biosciences (MBX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL